1. Home
  2. MTH vs ALKS Comparison

MTH vs ALKS Comparison

Compare MTH & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTH
  • ALKS
  • Stock Information
  • Founded
  • MTH 1985
  • ALKS 1987
  • Country
  • MTH United States
  • ALKS Ireland
  • Employees
  • MTH N/A
  • ALKS N/A
  • Industry
  • MTH Homebuilding
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTH Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • MTH Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • MTH 5.5B
  • ALKS 5.4B
  • IPO Year
  • MTH 1988
  • ALKS 1991
  • Fundamental
  • Price
  • MTH $71.44
  • ALKS $32.65
  • Analyst Decision
  • MTH Buy
  • ALKS Buy
  • Analyst Count
  • MTH 9
  • ALKS 13
  • Target Price
  • MTH $72.50
  • ALKS $39.50
  • AVG Volume (30 Days)
  • MTH 973.4K
  • ALKS 1.6M
  • Earning Date
  • MTH 04-23-2025
  • ALKS 04-30-2025
  • Dividend Yield
  • MTH 2.72%
  • ALKS N/A
  • EPS Growth
  • MTH 7.63
  • ALKS 3.47
  • EPS
  • MTH 10.72
  • ALKS 2.17
  • Revenue
  • MTH $6,395,035,000.00
  • ALKS $1,557,632,000.00
  • Revenue This Year
  • MTH $6.74
  • ALKS N/A
  • Revenue Next Year
  • MTH $8.29
  • ALKS $4.37
  • P/E Ratio
  • MTH $6.63
  • ALKS $15.03
  • Revenue Growth
  • MTH 4.18
  • ALKS N/A
  • 52 Week Low
  • MTH $68.71
  • ALKS $22.90
  • 52 Week High
  • MTH $106.99
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • MTH 45.90
  • ALKS 39.89
  • Support Level
  • MTH $68.71
  • ALKS $32.05
  • Resistance Level
  • MTH $74.38
  • ALKS $33.48
  • Average True Range (ATR)
  • MTH 1.90
  • ALKS 0.94
  • MACD
  • MTH 0.11
  • ALKS -0.26
  • Stochastic Oscillator
  • MTH 48.15
  • ALKS 17.86

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, which are comprised of ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments; homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes and providing warranty and customer services and the financial services segment offer title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: